Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on Tuesday to protest against the government ...

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...

A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

Students part of Project WeCan’s ‘Becoming a Writer’ course talk to the project director to learn about innovations at the ...

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...

When we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...

The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...